Acute lymphoblastic leukemia occurring as a second malignant neoplasm in a child

Journal of the Formosan Medical Association

Volumn 101, Issue 7, 2002, Pages 502-504

  Liou, Min Chang ^a   Lin, Kai Hsin ^a   Lu, Meng Yao ^a   Lin, Dong Tsamn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute lymphoblastic leukemia; Second malignant neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CD15 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CHILDHOOD CANCER; EARLY DIAGNOSIS; EWING SARCOMA; HUMAN; KARYOTYPING; LEUKEMOGENESIS; MALE; PATHOGENESIS; SCHOOL CHILD; SECOND CANCER;

BONE NEOPLASMS; CHILD; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEOPLASMS, SECOND PRIMARY; SARCOMA, EWING'S;

EID: 0036657399     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mike V, Meadows AT, D'Angio GJ: Incidence of second malignant neoplasms in children: results of an international study. Lancet 1982;ii:1326-31.
2. Meadows AT, Baum E, Fossati-Bellani F, et al: Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985;3:532-8.
3. de Vathaire F, Schweisguth O, Rodary C, et al: Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer 1989;59:448-52.
4. Kantarjian HM, Keating MJ, Walters RS, et al: Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 1986; 4:1748-57.
5. Tucker MA, Meadows AT, Boice JD Jr, et al: Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987;78:459-64.
6. Hunger SP, Sklar J, Link MP: Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol 1992;10:156-63.
7. Geetha N, SreedeviAmma N, Kusumakumary P, et al: Acute lymphoblastic leukemia occurring as a second malignancy: report of a case and review of literature. Pediatr Hematol Oncol 1999;16:267-70.
8. Swerdlow AJ, Douglas AJ, Hudson GV, et al: Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 1992; 304:1137-43.
9. Pedersen-Bjergaard J, Rowley JD: The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83:2780-6.
10. Pui CH, Ribeiro RC, Hancock ML, et al: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991; 325:1682-7.
11. Kumar L: Epipodophyllotoxins and secondary leukaemia. Lancet 1993;342:819-20.
12. Capranico G, Zunino F: DNA topoisomerase-trapping antitumour drugs. Eur J Cancer 1992;28A:2055-60.
13. Harris MB, Shuster JJ, Carroll A, et al: Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 1992;79:3316-24.
14. Raimondi SC: Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81:2237-51.
15. Li FP, Fraumeni JF Jr: Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 1969;71:747-52.
16. Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
17. Wadayama B, Toguchida J, Yamaguchi T, et al: p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 1993; 68:1134-9.
18. Felix CA, Hosler MR, Provisor D, et al: The p53 gene in pediatric therapy-related leukemia and myelodysplasia. Blood 1996;87:4376-81.
19. Stephenson CF, Bridge JA, Sandberg AA: Cytogenetic and pathologic aspect of Ewing's sarcoma and neuroectodermal tumor. Hum Pathol 1992;23:1270-7.
20. Rubnitz JE, Look AT: Molecular genetics of childhood leukemias. J Pediatr Hematol Oncol 1998;20:1-11.